Champions Oncology’s Webinar Channel

The transition from traditional 2D cell cultures to 3D tumor models has revolutionized preclinical oncology research by providing more physiologically relevant environments for studying tumor biology and drug responses. The advent of immunotherapies and stroma-targeted therapies has dramatically increased the need for more complex in vitro models replicating the TME and cancer immune interactions. However,…